SCHEMBL2126846

SCHEMBL2126846

Nc1nc(Nc2ccc(Br)cc2)nc(Nc2ccc(Br)cc2)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 8/20 0.58
▸ NPC1 O15118 6/20 0.58
▸ MAPT P10636 6/20 0.58
▸ KMT2A Q03164 5/20 0.58
▸ MEN1 O00255 4/20 0.58
▸ PABPC1 P11940 1/20 0.58
▸ AGPAT2 O15120 2/20 0.56
▸ CA12 O43570 1/20 0.53
▸ CA1 P00915 1/20 0.53
▸ CA2 P00918 1/20 0.53
▸ CA9 Q16790 1/20 0.53
▸ LMNA P02545 1/20 0.48
▸ MAPK1 P28482 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ GAA P10253 1/20 0.47
▸ JAK2 O60674 2/20 0.47
▸ ADRB2 P07550 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ TERT O14746 2/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2454054 0.96 RAB9A (0.58) RAB9ANPC1MAPTKMT2AMEN1
SCHEMBL25495161 0.89 MAPT (0.49) RAB9ANPC1MAPTKMT2AMEN1
SCHEMBL10910614 0.84 CA12 (0.68) RAB9ANPC1MAPTKMT2AMEN1
SCHEMBL15671751 0.83 ALDH1A1 (0.54) RAB9ANPC1MAPTKMT2AMEN1
SCHEMBL3125469 0.83 CA12 (0.56) RAB9ANPC1MAPTKMT2AMEN1
SCHEMBL1319443 0.79 CA12 (0.53) RAB9ANPC1MAPTKMT2AMEN1
SCHEMBL2253957 0.78 GAA (0.69) RAB9ANPC1MAPTKMT2AMEN1
SCHEMBL2410637 0.78 RAB9A (0.83) RAB9ANPC1MAPTKMT2AMEN1
Barbital SCHEMBL1650226 0.78 AGPAT2 (0.43) RAB9ANPC1MAPTKMT2AMEN1
SCHEMBL13622458 0.76 AGPAT2 (0.77) RAB9ANPC1MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1608339-B8 PHARMACEUTICAL CO-CRYSTAL OF CELECOXIB-NICOTINAMIDE MCNEIL PPC INC (US) 2012-04-25 — — EP disclosed
EP-1608339-A1 PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS OF DRUGS SUCH AS CARBAMAZEPINE, CELECOXIB, OLANZAPINE, ITRACONAZOLE, TOPIRAMATE, MODAFINIL, 5-FLUOROURACIL, HYDROCHLOROTHIAZIDE, ACETAMINOPHEN, ASPIRIN, FLURBIPROFEN, PHENYTOIN AND IBUPROFEN Transform Pharmaceuticals, Inc. (US) 2005-12-28 — — EP disclosed
WO-2004078161-A1 PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS OF DRUGS SUCH AS CARBAMAZEPTINE, CELECOXIB, OLANZAPINE, ITRACONAZOLE, TOPIRAMATE, MODAFINIL, 5-FLUOROURACIL, HYDROCHLOROTHIAZIDE, ACETAMINOPHEN, ASPIRIN, FLURBIPROFEN, PHENYTOIN AND IBUPROFEN TRANSFORM PHARMACEUTICALS, INC. (US) 2004-09-16 — — WO disclosed
Send feedback